Nello Mainolfi - Dec 8, 2022 Form 4 Insider Report for Kymera Therapeutics, Inc. (KYMR)

Role
Chief Executive Officer, Director
Signature
/s/ Bruce N. Jacobs, as Attorney-in-Fact
Stock symbol
KYMR
Transactions as of
Dec 8, 2022
Transactions value $
$20,800
Form type
4
Date filed
12/8/2022, 05:11 PM
Previous filing
Oct 17, 2022
Next filing
Mar 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KYMR Common Stock Options Exercise $20.8K +10K +1.77% $2.08* 574K Dec 8, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KYMR Stock Option (Right to Buy) Options Exercise $0 -10K -34.81% $0.00 18.7K Dec 8, 2022 Common Stock 10K $2.08 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This number includes 1,769 shares acquired under the Registrant's employee stock purchase plan on December 1, 2022.
F2 The shares underlying this stock option shall vest upon the achievement of specified performance-based milestones.